Founder Anders Ljungqvist Resigning From Board Due To Health Reasons
Oct 18 (Reuters) - RhoVac AB RHOVAC.TE :
* RHOVAC AB - BOARD MEMBER AND CO-FOUNDER ANDERS LJUNGQVIST
IS
RESIGNING FROM BOARD AT HIS OWN REQUEST DUE TO HEALTH REASONS
Source text for Eikon: ID:nPn1ScYfka
Further company coverage: RHOVAC.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chosa Oncology AB
See all newsBrief: Chosa Oncology Appoints Gerton Jönsson As New Chief Financial Officer
Brief: CHOSA Oncology AB Says Postpones Publication Of Interim Report Q4 2024
Brief: Chosa Oncology Carried Out Directed Issue Of Sek 1,55 Mln To Further Increase Business Development Activities
Brief: Chosa Oncology Announces Decision To Postpone Release Of Interim Report For Q2 2023
Brief: Chosa Oncology AB Publishes Results From Clinical Phase 2 Trial Of Liposomal Formulation In Breast Cancer, Using Predictive Marker For Cisplatin